BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18287411)

  • 1. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations.
    Lin JW; Lin CC; Chen WT; Lin SM
    Kaohsiung J Med Sci; 2014 Aug; 30(8):396-401. PubMed ID: 25002377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical study of percutaneous transhepatic radiofrequency ablation combined with tumor edge of percutaneous absolute ethanol injection on liver cancer adjacent to major blood vessels].
    Du JD; Liu R; Jiao HB; Xiang DD; Yin HN; Li ZC; Li T; Zhu ZM; Li ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):352-5. PubMed ID: 21645443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
    Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
    Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
    Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
    Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
    Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
    Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.
    Kim SH; Lim HK; Choi D; Lee WJ; Kim SH; Kim MJ; Kim CK; Jeon YH; Lee JM; Rhim H
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S327-33. PubMed ID: 16632696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.
    Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
    AJR Am J Roentgenol; 2012 Dec; 199(6):1393-401. PubMed ID: 23169736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.